Advantages of everolimus therapeutic drug monitoring in oncology when drug-drug interaction is suspected: A case report.
Geoffrey StrobbeDiane PannierIlyes SakjiAlexandre VillainFrédéric FeutryGuillaume MarliotPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
Therapeutic drug monitoring for everolimus is important for potential drug interactions or the occurrence of severe adverse events. In such cases, dose adjustments should be managed according to everolimus plasma concentrations. Clear oncological recommendations regarding plasma everolimus thresholds are required for a successful follow-up of the patient's condition and to ensure adequate response to treatment.